Risk Factors of Ketosis in Obese Ketosis-Prone Diabetic Patients: A Case-Control Study

作者: Li Shi , Liang Zhou , Juan Liu , Yang Ding , Xin-hua Ye

DOI: 10.1007/S13300-020-00800-6

关键词: Insulin resistanceKetosis-prone diabetesDiabetes mellitusInsulinType 2 diabetesInternal medicineKetosisBody mass indexMedicineGastroenterologyGlycated hemoglobin

摘要: Different types of ketosis-prone obese diabetic patients are seen in the clinic. At present, mechanism responsible for ketosis onset these remains unclear, and we do not know how should be optimally treated to prevent recurrent ketosis. Therefore, this study aims investigate risk factors (OB-KPD) patients. In an observational case-control study, primary OB-KPD [body mass index (BMI) ≥ 28 kg/m2] were selected as group (OB-KPD group), type 2 diabetes served control (OB-T2DM group). Clinical diagnostic assessments fasting plasma glucose (FPG), glycated hemoglobin (HbA1c), blood lipid, area under curve serum C-peptide (AUCC-P) after steamed bread meal, insulin sensitivity (ISI), β-hydroxybutyric acid (β-HB) free fatty (FFA) vlaues subjects collected. Subjects followed up 1 year determine likelihood therapy cessation whether recurred by assessing clinical chemistry parameters at 1-year follow-up. Seventy-five screened, which 15 included several identified reasons. On enrollment, displayed significantly higher FPG, HbA1c FFA levels than OB-T2DM (p < 0.01), while AUCC-P ISI values lower (p < 0.01 p = 0.03). Statistical analysis showed that increases β-HB associated with increased decreased values. Furthermore, decreases closely The occurrence may related lipid metabolism disorders, resistance β-cell secretory functions. This work was registered Chinese Trial Registry trial registration identifier no. ChiCTR1900025909.

参考文章(11)
Jacques Delarue, Christophe Magnan, Free fatty acids and insulin resistance. Current Opinion in Clinical Nutrition and Metabolic Care. ,vol. 10, pp. 142- 148 ,(2007) , 10.1097/MCO.0B013E328042BA90
Steven E. Kahn, Rebecca L. Hull, Kristina M. Utzschneider, Mechanisms linking obesity to insulin resistance and type 2 diabetes Nature. ,vol. 444, pp. 840- 846 ,(2006) , 10.1038/NATURE05482
A. Pinero-Pilona, P. Litonjua, L. Aviles-Santa, P. Raskin, Idiopathic type 1 diabetes in dallas, Texas: A 5-year experience Diabetes Care. ,vol. 24, pp. 1014- 1018 ,(2001) , 10.2337/DIACARE.24.6.1014
J. Valabhji, M. Watson, J. Cox, C. Poulter, C. Elwig, R. S. Elkeles, Type 2 diabetes presenting as diabetic ketoacidosis in adolescence. Diabetic Medicine. ,vol. 20, pp. 416- 417 ,(2003) , 10.1046/J.1464-5491.2003.00942.X
A. Balasubramanyam, G. Garza, L. Rodriguez, C. S. Hampe, L. Gaur, A. Lernmark, M. R. Maldonado, Accuracy and predictive value of classification schemes for ketosis-prone diabetes Diabetes Care. ,vol. 29, pp. 2575- 2579 ,(2006) , 10.2337/DC06-0749
María A. Ramos-Román, Antonio Piñero-Piloña, Beverley Adams-Huet, Philip Raskin, Comparison of type 1, type 2, and atypical ketosis-prone diabetes at 4 years of diabetes duration. Journal of Diabetes and Its Complications. ,vol. 20, pp. 137- 144 ,(2006) , 10.1016/J.JDIACOMP.2006.01.005
F. Mauvais-Jarvis, E. Sobngwi, R. Porcher, J.-P. Riveline, J.-P. Kevorkian, C. Vaisse, G. Charpentier, P.-J. Guillausseau, P. Vexiau, J.-F. Gautier, Ketosis-prone type 2 diabetes in patients of sub-Saharan African origin: clinical pathophysiology and natural history of beta-cell dysfunction and insulin resistance. Diabetes. ,vol. 53, pp. 645- 653 ,(2004) , 10.2337/DIABETES.53.3.645
S. G. Patel, J. W. Hsu, F. Jahoor, I. Coraza, J. R. Bain, R. D. Stevens, D. Iyer, R. Nalini, K. Ozer, C. S. Hampe, C. B. Newgard, A. Balasubramanyam, Pathogenesis of A−β+ Ketosis-Prone Diabetes Diabetes. ,vol. 62, pp. 912- 922 ,(2013) , 10.2337/DB12-0624
G. E. Umpierrez, D. Smiley, G. Robalino, L. Peng, A. R. Gosmanov, A. E. Kitabchi, Lack of Lipotoxicity Effect on β-Cell Dysfunction in Ketosis-Prone Type 2 Diabetes Diabetes Care. ,vol. 33, pp. 626- 631 ,(2010) , 10.2337/DC09-1369
Harold E. Lebovitz, Mary Ann Banerji, Ketosis-Prone Diabetes (Flatbush Diabetes): an Emerging Worldwide Clinically Important Entity Current Diabetes Reports. ,vol. 18, pp. 120- 120 ,(2018) , 10.1007/S11892-018-1075-4